Loading
SA
ScandiDos AB Stock: price and insider trades · Sweden
1 insider bought €7,990 of shares over the last 90 days, the latest by Olof Stranding, filed 13 Oct 2026.
ScandiDos AB: what insiders have been doing
ScandiDos AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Between 22 October 2025 and 22 October 2026, 3 insiders published 5 filings.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €9,373. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €7,990, bought by Olof Stranding and made public on 13 October 2026 (0.21% of market cap). Among those who bought: 1 board member and 1 chief executive.
The last purchase on record was published on 13 October 2026, which is 10 days ago. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.
With 5 filings in twelve months, the company is quieter than the median of 8 filings across the 882 companies we follow on the same exchange. Looking back to 2016, when coverage begins, insiders filed 31 purchases and 5 sales.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
61
Thresholds
n/a
Buy Volume
€387,592
31 ops. · all time
Sell Volume
€2M
5 ops. · all time
Who traded when
BuySaleFredrik Ljungberg4 buys
Fredric Eliasson3 buys
Olof Stranding1 buy
Fundamental score
Ranked 21,530 of 26,284 companies
29.1
score / 100
Value17
Quality41
FCF yld-9.4%
Earn yld-8.0%
EV/EBITDA·
ROE-18%
Gross mgn82%
Net mgn-6.3%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended April 2026 · cache
SEK 0.60
Analyst consensus
Income statement
RevenueSEK 54.2M
Gross profitSEK 44.3M82% margin
EBITDA-SEK 722k-1% margin
Net income-SEK 3.4M-16.8% margin
Valuation
P/Book0.9x
Beta0.62
Balance sheet & cash
Market capSEK 42.8M
Free Cash Flow-SEK 4M
Debt / Equity5%
Profitability & ownership
ROE-18.3%
ROA-6.6%
% insiders73.4%
% institutions4.6%
Last declaration on 13 October 2026
Declarations61 total
150,000 shares@ SEK 0.600.21% mcap100.0% of flowAktieISIN SE0005768124FI:csv-2b02e61683031040e4f0
Canonical exit: 10 Jan 2027 (T+90)
641,979 shares@ SEK 0.904.9% of flowBTA (betald tecknad aktie)ISIN SE0029301803FI:csv-1fcb342bade9a5ba2533
2,400,000 shares@ SEK 0.9018.6% of flowBTA (betald tecknad aktie)ISIN SE0029301803FI:csv-616c1b792019d065c4a3
9,911,936 shares@ SEK 0.9076.5% of flowBTA (betald tecknad aktie)ISIN SE0029301803FI:csv-e753f1685850ef160590
14,732 shares@ SEK 1.0250.031% mcap100.0% of flowAktieISIN SE0005768124FI:A003T134-1
Canonical exit: 25 Jan 2026 (T+90)
77,101 shares@ SEK 1.680.7% of flowAktieISIN SE0005768124FI:csv-193bab668838c89dcce1
Canonical exit: 30 Mar 2025 (T+90)
77,101 shares@ SEK 1.681.4% of flowAktieISIN SE0005768124FI:csv-bbf9b9d6783eaa2c41ea
Canonical exit: 30 Mar 2025 (T+90)
75,000 shares@ SEK 1.600.6% of flowAktieISIN SE0005768124FI:csv-2590272cf154d6fe8a79
Canonical exit: 20 Mar 2025 (T+90)
75,000 shares@ SEK 1.601.3% of flowAktieISIN SE0005768124FI:csv-925e7b332e2caef11635
Canonical exit: 20 Mar 2025 (T+90)
75,000 shares@ SEK 1.600.6% of flowAktieISIN SE0005768124FI:csv-43b980f8a514e47ab8cc
Canonical exit: 19 Mar 2025 (T+90)
75,000 shares@ SEK 1.601.3% of flowAktieISIN SE0005768124FI:csv-ed59cedcab01a4790f4c
Canonical exit: 19 Mar 2025 (T+90)
1,161,442 shares@ SEK 1.609.5% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-d002357604ae4afe49c0
1,161,442 shares@ SEK 1.6020.3% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-afecca581ae21e5fa57f
1,161,442 shares@ SEK 1.6020.4% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-6729e1db57e98c4ab527
26,730 shares@ SEK 1.603.2% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-43b5b5ceaafa804ff0e4
FörvärvISIN ScandiDos AB EM 03/2024FI:csv-c8706c44fc8891ed324f
3,128,302 shares@ SEK 1.6025.8% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-07a6656946a6f5d0b85e
3,128,302 shares@ SEK 1.6055.0% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-318993e47717444c8adc
1,152,630 shares@ SEK 1.60100.0% of flowAktieISIN SE0005768124FI:csv-b7a892ffb96f6962403e
Canonical exit: 22 Jul 2024 (T+90)
71,500 shares@ SEK 1.608.6% of flowBTA (betald tecknad aktie)ISIN SE0005768124FI:csv-6447550f634b72a4a563
31,000 shares@ SEK 2.445.6% of flowAktieISIN SE0005768124FI:csv-a3d2daa8f867c0bf1b8d
Canonical exit: 17 Sept 2023 (T+90)
40,000 shares@ SEK 2.889.8% of flowAktieISIN SE0005768124FI:csv-2426484b787673a97ca4
Canonical exit: 14 Mar 2022 (T+90)
9,964 shares@ SEK 3.2518.8% of flowAktieISIN SE0005768124FI:csv-aa28632c199f07bc7e51
Canonical exit: 23 Dec 2021 (T+90)
35,000 shares@ SEK 3.309.9% of flowAktieISIN SE0005768124FI:csv-f0e871628392f33dada5
Canonical exit: 22 Dec 2021 (T+90)
4,149,757 shares@ SEK 3.8598.9% of flowAktieISIN SE0005768124FI:csv-8f15ddbc7abf3cf5b9bf
25 of 61 declarations
About ScandiDos AB
ScandiDos AB is a company focused on developing dosimetry solutions for radiotherapy. It is listed on the Stockholm Stock Exchange (XSTO).
